Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease

Annals of the New York Academy of Sciences

Volumn 854, Issue , 1998, Pages 277-290

  Onorato, Joelle M ^a   Thorpe, Suzanne R ^a   Baynes, John W ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Department of Chemistry and Biochemistry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 HYDROXYPHENYL)ALANINE; 3 NITROTYROSINE; 4 HYDROXYNONENAL; BIOLOGICAL MARKER; CARBOHYDRATE; CELL PROTEIN; CHLOROTYROSINE; DITYROSINE; GLYOXAL; LYSINE DERIVATIVE; MALONALDEHYDE; METHIONINE SULFOXIDE; METHYLGLYOXAL; PENTOSIDINE; PLASMA PROTEIN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

AGING; ATHEROSCLEROSIS; BIOLOGY; CONFERENCE PAPER; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LIPID OXIDATION; MASS SPECTROMETRY; OXIDATIVE STRESS; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; URINE;

EID: 0032422401     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09909.x     Document Type: Conference Paper

References (75)

1. HALLIWELL, B. & J.M.C. GUTTERIDGE. 1989. Free Radicals in Biology and Medicine, 2nd ed. Clarendon Press. Oxford.
2. BAYNES, J.W. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
3. REQUENA, J.R., M.X. FU, M.U. AHMED, A.J. JENKINS, T.J. LYONS & S.R. THORPE. 1996. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 11 (Suppl 1): 48-53.
4. WELLS-KNECHT, K.J., E. BRINKMANN, M.C. WELLS-KNECHT, J.E. LITCHFIELD, M.U. AHMED, S. REDDY, D.V. ZYZAK, S.R. THORPE & J.W. BAYNES. 1996. New biomarkers of Maillard reaction damage to proteins. Nephrol. Dial. Transplant. 11 (Suppl 1): 41-47.
5. THORNALLEY, P.J. 1996. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol. Metab. 3: 149-166.
6. DEOENHARDT, T.P, E. BRINKMANN-FRYE, S.R. THORPE & J.W. BAYNES. 1998. Role of carbonyl stress in aging and age-related diseases. In The Maillard Reaction in Foods and Medicine. J. O'Brien, H.E. Nursten, M.J.C. Crabbe & J.M. Ames, Eds.:3-10. The Royal Society of Chemistry. London.
7. HORIUCHI, S. & N. ARAKI. 1994. Advanced glycation end products of the Maillard reaction and their relation to aging. Gerontology 40: 10-15.
8. THORPE, S.R. & J.W. BAYNES. 1996. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs & Aging 9: 69-77.
9. DEAN, R.T., S. Fu, R. STOCKER & M.J. DAVIES. 1997. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324: 1-18.
10. WELLS-KNECHT, M.C., T.J. LYONS, D.R. MCCANCE, S.R. THORPE & J.W. BAYNES. 1997. Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes: Evidence against a generalized increase in oxidative stress in diabetes. J. Clin. Invest. 100: 839-846.
11. HAZEN, S.L. & J.W. HEINECKE. 1997. 3-Chlorotyrosine, a specific marker of myeloperoxidasecatalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99: 2075-2081.
12. LEEUWENBURGH, C, M.M. HARDY, S.L. HAZEN, P. WAGNER, S. OH-ISHI, U.P. STEINBRECHER & J.W. HEINECKE. 1997. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272: 1433-1436.
13. LEEUWENBURGH, C., J.E. RASMUSSEN, F.F. HSU, D.M. MUELLER, S. PENNATHUR & J.W. HEINECKE. 1997. Mass spectrophotometric quantitation of markers of protein oxidation by tyrosyl radical, copper and hydroxyl radical in low density lipoprotein isolate from human atherosclerotic plaques. J. Biol. Chem. 272: 3520-3526.
14. HUGGINS, T.G., M.C. WELLS-KNECHT, N. DETORIE, S.R. THORPE & J.W. BAYNES. 1993. Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation of proteins. J. Biol. Chem. 268: 12341-12347.
15. STADTMAN, E.R. 1995. The status of oxidatively modified proteins as a marker of aging. In Molecular Aspects of Aging. K. Esser & G.W. Martin, Eds.: 129-143. John Wiley. New York.
16. ε-(carboxyethyl)Iysine, a product of chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem. J. 324: 565-570.
17. LAL, S., B.S. SZWERGOLD, A.H. TAYLOR, W.C. RANDALL, F. KAPPLER, K. WELLS-KNECHT, J.W. BAYNES & T.R. BROWN. 1995. Metabolism of fructose-3-phosphate in the diabetic rat lens. Arch. Biochem. Biophys. 318: 191-199.
18. THORNALLEY, P.J. 1990. The glyoxalase system: New developments toward functional characterization of a metabolic pathway fundamental to life. Biochem. J. 269: 1-11.
19. DYER, D., J. DUNN, S. THORPE, K. BAILIE, T. LYONS, D. McCANCE & J. BAYNES. 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91: 2463-2469.
20. ZYZAK, D.V. 1995. Studies on the Maillard reaction: Reaction of 3-deoxygIucosone with arginine residues in protein. Ph.D. thesis, University of South Carolina. Columbia, SC.
21. WESTWOOD, M.E., O.K. AGIROV, E.A. ABORDO & P.J. THORNALLEY. 1997. Methylglyoxal-modified arginine residues - a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim. Biophys. Acta 1356: 84-94.
22. ESTERBAUER, H. & P. RAMOS. 1996. Chemistry and pathophysiology of oxidation of LDL. Rev. Physiol. Biochem. Pharmacol. 127: 31-64.
23. REQUENA, J.R., M.X. Fu, M.U. ARMED, A.J. JENKINS, T.J. LYONS, J.W. BAYNES & S.R. THORPE. 1997. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem. J. 322: 317-325.
24. ε-(carboxymethyl)Iysine (CML), is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271: 9982-9986.
25. BOWIE, A., D. OWENS, P. COLLINS, A. JOHNSON & G.H. TOMKIN. 1993. Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient. Atherosclerosis 102: 60-67.
26. HAZELL, L.J., L. ARNOLD, D. FLOWERS, G. WAEG, E. MALLE & R. STOCKER. 1996. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97: 1535-1544.
27. MALLE, E., C. WOENCKHAUS, G. WAEG, H. ESTERBAUER, E.F. GRONE & H.J. GROENE. 1997. Immunoloaical evidence of hypochlorite-modified proteins in human kidney. Am. J. Pathol. 150: 603-615.
28. WU, G.S., J. ZHANG & N.A. RAO. 1997. Peroxynitrite and oxidalive damage in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 38: 1333-1339.
29. ISCHIROPOULOS, H., A.G. AL-MEHDI & A.B. FISHER. 1995. Reactive species in ischemic rat lung injury: Contribution of peroxynitrite. Am. J. Physiol. 269 (Part 1): L158-L164.
30. BECKMAN, J.S., Y.Z. YE, P.C. ANDERSON, J. CHEN-, M.A. ACCAVITTI, M.M. TARPEY & C.R. WHITE. 1994. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunochemistry. Biol. Chem. Hoppe-Seyler 375: 81-88.
31. LEVINE, R.L., J.A. WILLIAMS, E.R. STADTMAN & E. SHACTER. 1994. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233: 346-357.
32. Buss, H., T.P. CHAN, K.B. SLUIS, N.M. DOMIGAN & C.C. WINTERBOURN. 1997. Protein carbonyl measurement by a sensitive ELISA method. Free Radical Biol. Med. 23: 361-366.
33. ARAKI, N., N. UENO, B. CHAKRABARTI, Y. MORINO & S. HORIUCHI. 1992. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with age. J. Biol. Chem. 267: 10211-10214.
34. ε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35: 8075-8081.
35. DUNN, J.A., S.S. PATRICK, S.R. THORPE & J.W. BAYNES. 1989. Oxidation of glycated proteins: Age-dependent accumulation of carboxymethyllysinc in lens proteins. Biochemistry 28: 9464-9468.
36. MAKITA, Z., H. VLASSARA, A. CERAMI & R. BUCALA. 1992. Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 267: 5133-5138.
37. MAKITA, Z., S. RADOFF, E.J. RAYFIELD, Z. YANG, E. SKOLNIK, V. DELANEY, E.A. FRIEDMAN, A. CERAMI & H. VLASSARA. 1991. Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 325: 836-842.
38. BEISSWENGER, P., Z. MAKITA, T. CURPHEY, L. MOORE, S. JEAN, T. BRINCK-JOHNSEN, R. BUCALA & H. VLASSARA. 1995. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44: 824-829.
39. SELL, D.R. & V.M. MONNIER. 1989. Structure elucidation of a senescence cross-link from human extracellular matrix: Implication of pentoses in the aging process. J. Biol. Chem. 264: 21597-21602.
40. NAKAMURA, S., Z. MAKITA, S. ISHIKAWA, K. YASUMURA, W. FUJII, K. YANAGISAWA, T. KAWATA & T. KOIKE. 1997. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 46: 895-899.
41. RUMBLE, J.R., M.E. COOPER, T. SOULIS, A. Cox, L. Wu, S. YOUSSEF, M. JASIK, G. JERUMS & R.E. GILBERT. 1997. Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products. J. Clin. Invest. 99: 1016-1027.
42. PAPANASTASIOU, P., L. GRASS, H. RODELA, A. PATRIKAREA, D. OREOPOULOS & E. DIAMANDIS. 1994. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int. 46: 216-222.
43. ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99: 457-168.
44. ε-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34: 10872-10878.
45. NAKAYAMA, H., S. TANEDA, T. MITSUHASHI, S. KUWAJIMA, S. AOKI, Y. KURODA, K. MISAWA, K. YANAGISAWA & S. NAKAGAWA. 1991. Characterization of antibodies to advanced glycosylation end products in protein. J. Immunol. Methods 140: 119-125.
46. ε-(carboxymethyl)lysine is increased in uremia. Kidney Int. 52: 1064-1067.
47. BERG, T.J., P.A. TORJESEN, J.T. CLAUSEN, K. DAHL-JORGENSEN, H.-J. BANGSTAD, H. VOGT & K.F. HANSSEN. 1997. Carboxymethyllysine (CML) is increased in serum of children and adolescents with IDDM. Diabetologia 40 (Suppl. 1): A586.
48. KUME, S., M. TAKEYA, T. MORI, N. ARAKI, H. SUZUKI, S. HORIUCHI, T. KODAMA, Y. MIYAUCHI & K. TAKAHASHI. 1995. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147: 654-667.
49. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. J. Clin. Invest. 93: 521-528.
50. VITEK, M.P., K. BHATTACHARYA, J.M. GLENDENING, E. STOPA, H. VLASSARA, R. BUCALA, K. MANOGUE & A. CERAMI. 1994. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91: 4766-4770.
51. SMITH, M.A., A. TANEDA, P.L. RICHEY, S. MIYATA, S.-D. YAN, D. STERN, L. SAYRE, V.M. MONNIER & G. PERRY. 1994. Advanced Maillard reaction end products are associated with Alzheimer Disease. Proc. Natl. Acad. Sci. USA 91: 5170-5174.
52. ε-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. J. Invest. Dermatol. 108: 797-802.
53. NIWA, T., T. KATSUZAKI, S. MIYAZAKI, T. MIYAZAKI, Y. ISHIZAKI, F. HAYASE, N. TATEMICHI & Y. TAKEI. 1997. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J. Clin. Invest. 99: 1272-1280.
54. Fu, S., M-X. Fu, J.W. BAYNES, S.R. THORPE & R.T. DEAN. 1998. Presence of DOPA and amino acid hydroperoxides in protein modified with advanced glycation end products (AGEs): Amino acid oxidation products as possible source of oxidative stress induced by AGE-proteins. Biochem. J. 330: 233-239.
55. HAYASE, F., R.H. NAGARAJ, S. MIYATA, F.G. NJOROGE & V.M. MONNIER. 1989. Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J. Biol. Chem. 263: 3758-3764.
56. TANEDA, S. & V.M. MONNIER. 1994. ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin. Chem. 40: 1766-1773.
57. HABERLAND, M.E., D. FONG & L. CHENG. 1988. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241: 215-218.
58. YLÄ-HERTTUALA, S., W. PALINSKI, M.E. ROSENFELD, S. PARTHASARATHY, T.E. CAREW, S. BUTLER, J.L. WITZTUM & D. STEINBERG. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
59. YAN, S.-D., X. CHEN, A.M. SCHMIDT, J. BRETT, G. GODMAN, Y.-S. ZOU, C.W. SCOTT, C. CAPUTO, T. FRAPPIER, M.A. SMITH, G. PERRY, S.-H. YEN & D. STERN. 1994. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidative stress. Proc. Natl. Acad. Sci. USA 91: 7787-7791.
60. ANDO, Y, N. NYHLIN, O. SUHR, G. HOLMGREN, K. UCHIDA, M. EL SAHLY, T. YAMASHITA, H. TERESAKI, M. NAKAMURA, M. UCHINO & M. ANDO. 1997. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem. Biophys. Res. Commun. 232: 497-502.
61. HOUGLUM, K., M. FILIP, J.L. WITZTUM & M. CHOJKIER. 1990. Malondialdehyde and 4-hydroxynonenal adducts in plasma and liver of rats with iron overload. J. Clin. Invest. 86: 1991-1998.
62. KIM, J.G., F. SABBAGH, N. SANTAMAN, J.N. WILCOX, R.M. MEDFORD & S. PARTHASARATHY. 1997. Generation of a polyclonal antibody against lipid peroxide modified proteins. Free Radical Biol. Med. 23: 251-259.
63. BUCALA, R., Z. MAKITA, T. KOSCHINSKY, A. CERAMI & H. VLASSARA. 1993. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA 90: 6434-6438.
64. REQUENA, J.R., M. AHMED, C.W. FOUNTAIN, T.P. DEGENHARDT, S. REDDY, C. PEREZ, T.J. LYONS, A.J. JENKINS, J.W. BAYNES & S.R. THORPE. 1997. Carboxymethylethanolamine, a biomarker of phosphoplipid modification during the Maillard reaction in vivo. J. Biol. Chem. 272: 17473-17479.
65. JAIN, S.K., R. MCVIE, J. DUETT & J.J. HERBST. 1989. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38: 1539-1543.
66. PONGOR, S., P.C. ULRICH, F.A. BENCSATH & A. CERAMI. 1984. Aging of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. Natl. Acad. Sci. USA 81: 2684-2688.
67. NAGARAJ, R.H., I.N. SHIPANOVA & P.M. FAUST. 1996. Protein cross-linking by the Maillard reaction: Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J. Biol. Chem. 271: 19338-19345.
68. NJOROGE, F.G., A.A. FERNANDES & V.M. MONNIER. 1988. Mechanism of formation of the putative advanced glycosylation end product and protein crosslink 2-(2-furoyl)-4(5)-(2-furanyl)-lHimidazole. J. Biol. Chem. 263: 10646-10652.
69. HORIUCHI, S., M. SHIGA, N. ARAKI, K. TAKATA, M. SAITOH & Y. MORINO. 1988. Evidence against in vivo presence of 2-(2-furoyl)-4(5)-(2-furanyl)-lH-imidazole, a major fluorescent advanced end product generated by nonenzymatic glycosylation. J. Biol. Chem. 263: 18821-18826.
70. PALINSKI, W., T. KOSCHINSKY, S.W. BUTLER, E. MILLER, H. VLASSARA, A. CERAMI & J.L. WITZTUM. 1995. Arterioscler. Thromb. Vase. Biol. 15: 571-582.
71. IENAGA, K., H. KAKITA, T. HOCHI, K. NAKAMURA, Y. NAKAZAWA, Y. FUKUNAGA, S. AOKI, G. HASEGAWA, Y. TSUTSUMI, Y. KITAGAWA & K. NAKAKO. 1996. Crossline-like structure accumulates a fluorescent advanced glycation end product in renal tissues of rats with diabetic nephropathy. Proc. Jpn. Acad. 72 (Ser B): 78-84.
72. HORIUCHI, S., N. ARAKI, K. NAKAMURA, K. IKEDA, Y. FUKUNAGA & K. IENAGA. 1996. A new fluorescent crosslinker (AGE-X1) isolated from AGE-lysine derivatives. Diabetes 45: 186A.
73. KONISHI, Y., F. HAYASE & H. KATO. 1994. Novel imidazolone compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in protein. Biosci. Biotech. Biochem. 58: 1953-1955.
74. GIARDINO, L, D. EDELSTEIN & M. BROWNLEE. 1994. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J. Clin. Invest. 94: 110-117.
75. MENG, J., N. SAKATA, S. TAKEBAYASHI, T. ASANO, T. FUTATA, N. ARAKI & S. HORIUCHI. 1996. Advanced glycation end products of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes 45: 1037-1043.